Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism

Ovarian cancer is most deadly gynecologic malignancies worldwide. Chemotherapy is the mainstay treatment for ovarian cancer. Despite the initial response is promising, frequent recurrence in patients with advanced diseases remains a therapeutic challenge. Thus, understanding the biology of chemoresi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shan-Shan, Ma, Jing, Wong, Alice S. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823988/
https://www.ncbi.nlm.nih.gov/pubmed/29468856
http://dx.doi.org/10.3802/jgo.2018.29.e32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823988/
https://www.ncbi.nlm.nih.gov/pubmed/29468856
http://dx.doi.org/10.3802/jgo.2018.29.e32

Ejemplares similares